PTK2 and cancer: When PTEN is active, it dephosphorylates FAK, disrupting the signaling needed to sustain focal adhesions and thus diminishing the migratory and invasive potential of cancer cells (Tamura et al., 1998, 1999; Schwab and Stock, 2014).